Alexion Investors Win Class Cert. Over Drug Sale Tactics

By Brian Steele · April 13, 2023, 10:27 PM EDT

A Connecticut federal judge on Thursday certified a class of Alexion investors who sued it over a double-digit plunge in its stock price that started when the public began learning of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Boston Retirement System v. Alexion Pharmaceuticals Inc et al

Case Number

Court

Connecticut

Nature of Suit

Securities/Commodities

Date Filed

December 29, 2016

Recent Articles By Brian

June 27, 2024
State AGs Want Stay Lifted In Generic Drug Pricing Suit
June 24, 2024
Judge Mulls BioXcel's Duty To Tell Investors Of FDA Troubles
June 24, 2024
Justices Pass On Conn. School Vaccine Mandate Fight
June 20, 2024
HHS Drug Pricing Program Flouts Constitution, Boehringer Says
June 13, 2024
Feds Get $4.6M In Deal Over Telehealth Billing Fraud Probe
June 07, 2024
Conn. Judge Pushes State For Proof In $11M Kickback Case
June 07, 2024
7 Health Insurers Eye Rate Hikes In Connecticut
May 23, 2024
Conn. Marketing Co., Competitor Settle Exec Poaching Suit
April 30, 2024
Aetna Resists State Court Remand In Provider Payment Suit
April 24, 2024
Conn. Healthcare Co. Will Pay $1.5M To End Data Breach Suit